A study of Ryplazim
Latest Information Update: 13 Aug 2020
At a glance
- Drugs Plasminogen (Primary)
- Indications Type I plasminogen deficiency
- Focus Therapeutic Use
- Sponsors Liminal BioSciences
- 13 Aug 2020 New trial record
- 10 Aug 2020 According to a Liminal Biosciences media release, additional clinical studies for Ryplazim anticipated in H2 2021.